Delineation of two distinct 6p deletion syndromesAngela Davies, Jiannis Ragoussis, Ghazala Mirza et al.|Human Genetics|1999Cited by 113
MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastomaAnneleen Beckers, Frank Speleman|Cancer Letters|2015Cited by 50
RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibitionCarolina Nunes, Frank Speleman|Science Advances|2022Cited by 47
MYCN-induced nucleolar stress drives an early senescence-like transcriptional program in hTERT-immortalized RPE cellsSofia Zanotti, Frank Speleman|Scientific Reports|2021Cited by 8
Supplementary Data 1 from Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic MarkersAndré Oberthuer, Matthias Fischer, Dilafruz Juraeva et al.|Unknown|2023Cited by 0